Debt-to-equity of Inhibrx, Inc. from 30 Jun 2021 to 31 Mar 2024

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Inhibrx, Inc. quarterly Debt-to-equity in % history and change rate from 30 Jun 2021 to 31 Mar 2024.
Inhibrx, Inc. Debt-to-equity for the quarter ending 31 Mar 2024 was 640%, a 76% decline year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Change (%)

Inhibrx, Inc. Quarterly Debt-to-equity (%)

Period	Value	YoY Chg	Change %	Date
Q1 2024	640%	-1978%	-76%	31 Mar 2024
Q4 2023	602%	-1081%	-64%	31 Dec 2023
Q3 2023	535%	-1049%	-66%	30 Sep 2023
Q2 2023	6822%	+6307%	+1223%	30 Jun 2023
Q1 2023	2617%	+2335%	+826%	31 Mar 2023
Q4 2022	1683%	+1489%	+766%	31 Dec 2022
Q3 2022	1584%	+1426%	+899%	30 Sep 2022
Q2 2022	515%	+412%	+398%	30 Jun 2022
Q1 2022	283%			31 Mar 2022
Q4 2021	194%			31 Dec 2021
Q3 2021	159%			30 Sep 2021
Q2 2021	103%			30 Jun 2021

* An asterisk sign (*) next to the value indicates that the value is likely invalid.